Leanne Carijn Helgers

Dr. Leanne Carijn Helgers

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2022 in The EMBO Journal
Verified
Journal Article
Open access
NTNienke H van Teijlingen
Nienke H van Teijlingen
LHLeanne Carijn Helgers
Leanne Carijn Helgers
RSRamin Sarrami‐Forooshani
Ramin Sarrami‐Forooshani
EZEsther M Zijlstra‐Willems
Esther M Zijlstra‐Willems
JHJohn L van Hamme
John L van Hamme
TGTeunis B.H. Geijtenbeek
Teunis B.H. Geijtenbeek
Dysbiosis of vaginal microbiota is associated with increased HIV‐1 acquisition, but the underlying cellular mechanisms remain unclear. Vaginal Langerhans cells (LCs) protect against mucosal HIV‐1 infection via autophagy‐mediated degradation of HIV‐1. As LCs are in continuous contact with bacterial members of the vaginal microbiome, we investigated the impact of commensal and dysbiosis‐associated vaginal (an)aerobic bacterial species on the antiviral function of LCs. Most of the tested bacteria did not affect the HIV‐1 restrictive function of LCs. However, Prevotella timonensis induced a vast uptake of HIV‐1 by vaginal LCs. Internalized virus remained infectious for days and uptake was unaffected by antiretroviral drugs. P. timonensis‐exposed LCs efficiently transmitted HIV‐1 to target cells both in vitro and ex vivo. Additionally, P. timonensis exposure enhanced uptake and transmission of the HIV‐1 variants that establish infection after sexual transmission, the so‐called Transmitted Founder variants. Our findings, therefore, suggest that P. timonensis might set the stage for enhanced HIV‐1 susceptibility during vaginal dysbiosis and advocate targeted treatment of P. timonensis during bacterial vaginosis to limit HIV‐1 infection.

18 June 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
LMLaura Mathä
Laura Mathä
LKLisette Krabbendam
Lisette Krabbendam
SHSergio Martinez Høyer
Sergio Martinez Høyer
BHBalthasar A. Heesters
Balthasar A. Heesters
KGKorneliusz Golebski
Korneliusz Golebski
IMItziar Martinez-Gonzalez
Itziar Martinez-Gonzalez
ILC2s are key players in type 2 immunity and contribute to maintaining homeostasis. ILC2s are also implicated in the development of type 2 inflammation–mediated chronic disorders like asthma. While memory ILC2s have been identified in mouse, it is unknown whether human ILC2s can acquire immunological memory. Here, we demonstrate the persistence of CD45RO, a marker previously linked to inflammatory ILC2s, in resting ILC2s that have undergone prior activation. A high proportion of these cells concurrently reduce the expression of the canonical ILC marker CD127 in a tissue-specific manner. Upon isolation and in vitro stimulation of CD127−CD45RO+ ILC2s, we observed an augmented ability to proliferate and produce cytokines. CD127−CD45RO+ ILC2s are found in both healthy and inflamed tissues and display a gene signature of cell activation. Similarly, mouse memory ILC2s show reduced expression of CD127. Our findings suggest that human ILC2s can acquire innate immune memory and warrant a revision of the current strategies to identify human ILC2s.

17 November 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
LHLeanne Carijn Helgers
Leanne Carijn Helgers
NKNadia C.H. Keijzer
Nadia C.H. Keijzer
JHJohn L. van Hamme
John L. van Hamme
JSJoris K. Sprokholt
Joris K. Sprokholt
TGTeunis B.H. Geijtenbeek
Teunis B.H. Geijtenbeek
Dengue virus (DENV) is the most disease-causative flavivirus worldwide. DENV as a mosquito-borne virus infects human hosts through the skin; however, the initial target cells in the skin remain unclear. In this study, we have investigated whether epidermal Langerhans cells (LCs) play a role in DENV acquisition and dissemination. We have used a human epidermal ex vivo infection model as well as isolated LCs to investigate infection by DENV. Notably, both immature and mature LCs were permissive to DENV infection in vitro and ex vivo, and infection was dependent on C-type lectin receptor langerin because blocking antibodies against langerin significantly reduced DENV infection in vitro and ex vivo. DENV-infected LCs efficiently transmitted DENV to target cells such as dendritic cells. Moreover, DENV exposure increased the migration of LCs from epidermal explants. These results strongly suggest that DENV targets epidermal LCs for infection and dissemination in the human host. These findings could provide potential drug targets to combat the early stage of DENV infection.

Verified
Journal Article
Open access
PDF file
LHLeanne Carijn Helgers
Leanne Carijn Helgers
KVKillian E. Vlaming
Killian E. Vlaming
TKTanja M. Kaptein
Tanja M. Kaptein
JEJulia Eder
Julia Eder
JDJanWillem Duitman
JanWillem Duitman
TGTeunis B.H. Geijtenbeek
Teunis B.H. Geijtenbeek
Human rhinovirus 16 (HRV-16) is a major cause of common colds and can exacerbate asthma and COPD, yet no approved antiviral treatments exist. Heparin, a highly sulfated polysaccharide, is known to block viral infection of many viruses that require attachment to heparan sulfate proteoglycans (HSPGs). Here, we investigated whether heparin inhibits HRV-16 infection. HRV-16 uses ICAM-1 as its attachment receptor and lacks a confirmed HSPG-binding mechanism. Notably, heparin inhibited HRV-16 infection in vitro in a dose- and time-dependent manner. Pre-treatment of either cells or virus particles with unfractionated heparin significantly reduced HRV-16 RNA expression at 24 and 48 h post-infection. In contrast, low-molecular-weight heparins blocked infection of HRV-16 significantly less effectively compared to unfractionated heparins. Our findings suggest that the inhibitory effect of unfractionated heparin on HRV-16 infection is likely independent of specific HSPGs interactions and may be mediated by the size and highly negative charge of unfractionated heparin. Importantly, the ability of unfractionated heparin to block viruses that do not require HSPGs for attachment implies a broader antiviral potential as a prophylactic or therapeutic agent against a variety of respiratory viruses.

19 March 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
PCPamela E. Capendale
Pamela E. Capendale
LHLeanne Carijn Helgers
Leanne Carijn Helgers
AAAnoop T. Ambikan
Anoop T. Ambikan
RSRenata Vieira de Sá
Renata Vieira de Sá
KWKatja C. Wolthers
Katja C. Wolthers
DPDasja Pajkrt
Dasja Pajkrt
Human immunodeficiency virus (HIV) can invade the central nervous system during the initial stages of infection and contribute to HIV-associated neurocognitive disorder, affecting up to 50% of people living with HIV (PLWH). To investigate HIV-1–induced immunometabolic changes in the brain, we used a three-dimensional microglia-embedded human neural organoid model. Transcriptomic analysis and genome-scale metabolic modeling revealed that HIV-1 infection led to more pronounced transcriptional changes in the presence of microglia, including upregulation of pro-inflammatory pathways. We identified CCR6, important for HIV-1 permissiveness, to be significantly upregulated upon infection. Metabolic analysis showed increased expression in metabolite transport-related genes, including solute carrier (SLC) genes and altered amino acid metabolism, particularly involving arginine, proline, and tyrosine. These microglia-driven immunometabolic changes may contribute to neuronal dysregulation and, subsequently, neurological complications, which are often observed in PLWH. Early detection of these alterations could support timely therapeutic intervention to improve HIV-related neurologic insult.

16 April 2026 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
KKKeshia Kroh
Keshia Kroh
ABAlisha D. Biharie
Alisha D. Biharie
EMEleanor Margaret Marshall
Eleanor Margaret Marshall
RRRedwan Rahmat
Redwan Rahmat
DSDebby Schipper
Debby Schipper
CECarmen Embregts
Carmen Embregts
Rabies is a fatal zoonotic infection caused by rabies virus (RABV), which is transmitted through the saliva of infected animals. Although most cases are caused by dog bites, superficial exposures such as bat bites or scratches can also lead to infection, although the underlying mechanisms remain poorly understood. We recently detected RABV-positive keratinocytes in skin samples of experimentally infected mice and naturally infected dogs, prompting us to investigate their role in rabies pathogenesis and the antiviral immune response. We confirmed that both the keratinocyte cell line HaCaT and primary keratinocytes are susceptible to RABV infection in vitro, with higher infection rates observed for the attenuated SAD P5/88 Potsdam and silver-haired bat RABV strains than for a dog-related strain. Keratinocytes showed a significant immune activation in response to these 2 strains, as measured by expression of relevant surface markers and cytokine release. To explore whether RABV can be transmitted from infected keratinocytes to neurons, we developed a coculture model using HaCaT and a neuronal cell line separated by a microporous membrane. Virus transfer to the neurons was observed while the barrier integrity remained intact, suggesting that keratinocytes may contribute to RABV transmission and neuroinvasion after superficial exposure.